Norman J Montalto1, Wayne O Wells. 1. Acordia National/Wells Fargo, 602 Virginia St. E., Charleston, West Virginia, 25327-1921, USA. norman.montalto@gwl.com
Abstract
PURPOSE: This study evaluated the performance characteristics of a novel rapid method for verifying smoking status in individuals by measurement of cotinine, the primary metabolite of nicotine, in saliva samples using an immunochromatographic strip in a "dipstick" format compared with liquid chromatography/mass spectrometry (LC/MS). MATERIALS AND METHODS: A prospective comparison was made of smoking status as determined by measurement of cotinine in urine by LC/MS (the gold standard) and in saliva using a semiquantitative dipstick assay that uses cotinine-specific monoclonal antibodies attached to gold particles and a series of avidity traps to measure cotinine levels (saliva NicAlert). One hundred seventy-two individuals from a family practice/general medical setting agreed to participate after informed consent and institutional review board approval. Saliva NicAlert tests were done by untrained operators who followed written directions. RESULTS: Comparison of smoking status as determined by urine cotinine measurement by LC/MS (50 ng/mL cutoff) with the saliva strip test results, averaged over the two operators, indicated that the saliva test strip results had a sensitivity of 99% and a specificity of 96%. Saliva NicAlert also identified four smokers who reported being nonsmokers but were confirmed to be smokers by LC/MS. CONCLUSIONS: The saliva NicAlert assay seems to be a valid, highly sensitive, and specific method for validating self-reported smoking status and may have clinical applications in selected medical settings.
PURPOSE: This study evaluated the performance characteristics of a novel rapid method for verifying smoking status in individuals by measurement of cotinine, the primary metabolite of nicotine, in saliva samples using an immunochromatographic strip in a "dipstick" format compared with liquid chromatography/mass spectrometry (LC/MS). MATERIALS AND METHODS: A prospective comparison was made of smoking status as determined by measurement of cotinine in urine by LC/MS (the gold standard) and in saliva using a semiquantitative dipstick assay that uses cotinine-specific monoclonal antibodies attached to gold particles and a series of avidity traps to measure cotinine levels (saliva NicAlert). One hundred seventy-two individuals from a family practice/general medical setting agreed to participate after informed consent and institutional review board approval. Saliva NicAlert tests were done by untrained operators who followed written directions. RESULTS: Comparison of smoking status as determined by urine cotinine measurement by LC/MS (50 ng/mL cutoff) with the saliva strip test results, averaged over the two operators, indicated that the saliva test strip results had a sensitivity of 99% and a specificity of 96%. Saliva NicAlert also identified four smokers who reported being nonsmokers but were confirmed to be smokers by LC/MS. CONCLUSIONS: The saliva NicAlert assay seems to be a valid, highly sensitive, and specific method for validating self-reported smoking status and may have clinical applications in selected medical settings.
Authors: Nada O F Kassem; Noura O Kassem; Sandy Liles; Sheila R Jackson; Dale A Chatfield; Peyton Jacob; Neal L Benowitz; Melbourne F Hovell Journal: Regul Toxicol Pharmacol Date: 2017-07-14 Impact factor: 3.271
Authors: S S Shin; R Laniado-Laborin; P G Moreno; T E Novotny; S A Strathdee; R S Garfein Journal: Int J Tuberc Lung Dis Date: 2013-11 Impact factor: 2.373
Authors: Neal L Benowitz; John T Bernert; Jonathan Foulds; Stephen S Hecht; Peyton Jacob; Martin J Jarvis; Anne Joseph; Cheryl Oncken; Megan E Piper Journal: Nicotine Tob Res Date: 2020-06-12 Impact factor: 4.244
Authors: Georg E Matt; Penelope J E Quintana; Joy M Zakarian; Eunha Hoh; Melbourne F Hovell; Melinda Mahabee-Gittens; Kayo Watanabe; Kathy Datuin; Cher Vue; Dale A Chatfield Journal: Tob Control Date: 2016-09-21 Impact factor: 7.552